Earnings Feed
Start Free
Home/Filings/4/0001209191-15-007720
4//SEC Filing

AUXILIUM PHARMACEUTICALS INC 4

Accession 0001209191-15-007720

CIK 0001182129operating
View on SEC.govCompany Profile

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 9:40 AM ET

Size

14.7 KB

Accession

0001209191-15-007720

Insider Transaction Report

Form 4
Period: 2015-01-29
AUXILIUM PHARMACEUTICALS INCAUXL
WILLS ALAN
EVP, Corporate Development
Transactions
  • Other

    Nonqualified Employee Stock Option (Right to Buy)

    2015-01-29$36.53/sh−35,000$1,278,550→ 0 total
    Exercise: $28.30From: 2015-02-18Exp: 2024-02-17→ Common Stock (35,000 underlying)
  • Other

    Common Stock

    2015-01-29$36.53/sh−30,743$1,123,042→ 0 total
  • Other

    Nonqualified Employee Stock Option (Right to Buy)

    2015-01-29$36.53/sh−10,000$365,300→ 0 total
    Exercise: $22.04From: 2012-02-17Exp: 2021-02-17→ Common Stock (10,000 underlying)
  • Other

    Nonqualified Employee Stock Option (Right to Buy)

    2015-01-29$36.53/sh−28,500$1,041,105→ 0 total
    Exercise: $19.51From: 2013-02-14Exp: 2022-02-13→ Common Stock (28,500 underlying)
  • Other

    Nonqualified Employee Stock Option (Right to Buy)

    2015-01-29$36.53/sh−28,125$1,027,406→ 0 total
    Exercise: $18.30From: 2014-02-07Exp: 2023-02-07→ Common Stock (28,125 underlying)
Footnotes (2)
  • [F1]In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these restricted stock units and unvested shares of restricted stock were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement.
  • [F2]In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these options were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement.

Documents

1 file

Issuer

AUXILIUM PHARMACEUTICALS INC

CIK 0001182129

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001182129

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:40 AM ET
Size
14.7 KB
View on SEC.gov